Article
Clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia.
Hormone research - 1 Jan 1997
Leclère J, Béné M C, Aubert V, Klein M, Pascal-Vigneron V, Weryha G, Faure G
Abstract excerpt
Activating mutations of TSH-R have been described in toxic nodules and more recently in familial nonautoimmune thyrotoxicosis. This last entity is still confused with familial Graves' disease and the aim of this study is to define its phenotype. Based on 49 patients coming from our first family and on the 4 other kindreds secondarily described in the literature, the phenotypic expression is: a high incidence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
